Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127395831 | 12739583 | 1 | I | 20160822 | 0 | 20160913 | 20160913 | DIR | US-FDA-350439 | FDA-CTU | 42.09 | YR | M | N | 120.20000 | KG | 20160913 | N | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127395831 | 12739583 | 1 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | N | D | 0 | 2000 | MG | |||||||
| 127395831 | 12739583 | 2 | PS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | N | D | 0 | 1500 | MG | |||||||
| 127395831 | 12739583 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 6 | C | INSULIN DETEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 8 | C | SIMETHICONE (DIMETHICONE) | DIMETHICONE | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 10 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 12 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 14 | C | ENOXAPARIN | ENOXAPARIN | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 16 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 18 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 20 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 22 | C | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 24 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 0 | ||||||||||||
| 127395831 | 12739583 | 26 | C | INSULIN ASPART | INSULIN ASPART | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127395831 | 12739583 | 1 | Sepsis |
| 127395831 | 12739583 | 2 | Sepsis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127395831 | 12739583 | HO |
| 127395831 | 12739583 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127395831 | 12739583 | Creatinine renal clearance increased | |
| 127395831 | 12739583 | Nephropathy toxic | |
| 127395831 | 12739583 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127395831 | 12739583 | 1 | 20160817 | 20160820 | 0 | |
| 127395831 | 12739583 | 2 | 20160818 | 20160818 | 0 |